Xeris Biopharma Holdings Statistics
Total Valuation
XERS has a market cap or net worth of $457.68 million. The enterprise value is $657.75 million.
Important Dates
The last earnings date was Friday, November 8, 2024, before market open.
Earnings Date | Nov 8, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
XERS has 149.08 million shares outstanding. The number of shares has increased by 5.01% in one year.
Current Share Class | 149.08M |
Shares Outstanding | 149.08M |
Shares Change (YoY) | +5.01% |
Shares Change (QoQ) | +0.44% |
Owned by Insiders (%) | 4.42% |
Owned by Institutions (%) | 43.67% |
Float | 142.50M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 2.35 |
Forward PS | 2.08 |
PB Ratio | n/a |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 3.51 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.79
Current Ratio | 1.79 |
Quick Ratio | 1.21 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -1.52 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -8.70% |
Return on Capital (ROIC) | -11.90% |
Revenue Per Employee | $496,979 |
Profits Per Employee | -$167,408 |
Employee Count | 377 |
Asset Turnover | 0.58 |
Inventory Turnover | 0.84 |
Taxes
Income Tax | -2.50M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +72.88% in the last 52 weeks. The beta is 1.28, so XERS's price volatility has been higher than the market average.
Beta (5Y) | 1.28 |
52-Week Price Change | +72.88% |
50-Day Moving Average | 3.03 |
200-Day Moving Average | 2.50 |
Relative Strength Index (RSI) | 47.67 |
Average Volume (20 Days) | 1,959,694 |
Short Selling Information
The latest short interest is 11.37 million, so 7.63% of the outstanding shares have been sold short.
Short Interest | 11.37M |
Short Previous Month | 11.57M |
Short % of Shares Out | 7.63% |
Short % of Float | 7.98% |
Short Ratio (days to cover) | 9.52 |
Income Statement
In the last 12 months, XERS had revenue of $187.36 million and -$63.11 million in losses. Loss per share was -$0.44.
Revenue | 187.36M |
Gross Profit | 152.44M |
Operating Income | -45.17M |
Pretax Income | -59.08M |
Net Income | -63.11M |
EBITDA | -33.06M |
EBIT | -45.17M |
Loss Per Share | -$0.44 |
Full Income Statement Balance Sheet
The company has $69.40 million in cash and $270.97 million in debt, giving a net cash position of -$201.56 million or -$1.35 per share.
Cash & Cash Equivalents | 69.40M |
Total Debt | 270.97M |
Net Cash | -201.56M |
Net Cash Per Share | -$1.35 |
Equity (Book Value) | -28.32M |
Book Value Per Share | -0.19 |
Working Capital | 71.79M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$31.49 million and capital expenditures -$780,000, giving a free cash flow of -$32.27 million.
Operating Cash Flow | -31.49M |
Capital Expenditures | -780,000 |
Free Cash Flow | -32.27M |
FCF Per Share | -$0.22 |
Full Cash Flow Statement Margins
Gross margin is 81.36%, with operating and profit margins of -24.11% and -33.69%.
Gross Margin | 81.36% |
Operating Margin | -24.11% |
Pretax Margin | -35.02% |
Profit Margin | -33.69% |
EBITDA Margin | -17.65% |
EBIT Margin | -24.11% |
FCF Margin | -21.40% |
Dividends & Yields
XERS does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -5.01% |
Shareholder Yield | -5.01% |
Earnings Yield | -13.83% |
FCF Yield | -7.07% |
Analyst Forecast
The average price target for XERS is $4.87, which is 58.63% higher than the current price. The consensus rating is "Buy".
Price Target | $4.87 |
Price Target Difference | 58.63% |
Analyst Consensus | Buy |
Analyst Count | 3 |
Revenue Growth Forecast (5Y) | 17.30% |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
XERS has an Altman Z-Score of -1.97 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -1.97 |
Piotroski F-Score | 2 |